Navigation Links
H2Diesel Holdings Announces Test Burn Agreement With Mirant Corp.
Date:12/19/2007

HOUSTON, Dec. 19 /PRNewswire-FirstCall/ -- H2Diesel Holdings, Inc. (OTC Bulletin Board: HTWO) announced today that it has entered into a Test Burn Agreement with Mirant Energy Trading LLC, a subsidiary of Mirant Corp. (NYSE: MIR) to demonstrate its proprietary biofuel technology in utility scale power generation applications.

The Agreement calls for H2Diesel to supply its biofuel for a gas turbine test program that will be performed in early 2008 at Mirant's Morgantown Generating Station, which consumed approximately 5 million gallons of distillate fuel oil in 2006. The test program will include the evaluation of both technical and environmental performance characteristics of H2Diesel's biofuel. If testing is successful, the parties intend to negotiate a mutually agreeable purchase agreement for H2Diesel's biofuel technology.

"We're excited to be teaming with Mirant, a recognized leader in reliable, affordable, and environmentally responsible energy supply to build on our recent successes as we continue to commercialize our proprietary renewable biofuel," said David A. Gillespie, president and CEO of H2Diesel. "We believe our fuel can be used in industrial and power generation applications to reduce our nation's dependence on foreign oil, and to reduce the emissions of greenhouse gasses and other pollutants. We look forward to successfully completing the testing program and to Mirant becoming one of our first large- scale electric generation customers."

"A successful test of H2Diesel's biofuel at Morgantown represents a significant opportunity for Mirant, our customers, and stakeholders," said John O'Neal, Mirant's senior vice president and chief commercial officer. "Use of renewable fuels at Morgantown, one of our lar
'/>"/>

SOURCE H2Diesel Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. H2Diesel Completes 3 Million Gallon Per Year Pilot Facility
2. H2Diesel Announces Appointment of Cary J. Claiborne as Chief Financial Officer
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
5. Lixte Biotechnology Holdings, Inc. Announces the Initial Trading of Its Common Stock Under the Symbol: LIXT
6. Zimmer Holdings Announces Support for Elimination of Super-Majority Voting Requirements
7. China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
Other Biology Technology:Masimo Initiates Full Market Release of First-Ever Noninvasive Continuous Hemoglobin Monitor 2Masimo Initiates Full Market Release of First-Ever Noninvasive Continuous Hemoglobin Monitor 3Masimo Initiates Full Market Release of First-Ever Noninvasive Continuous Hemoglobin Monitor 4Masimo Initiates Full Market Release of First-Ever Noninvasive Continuous Hemoglobin Monitor 5Masimo Initiates Full Market Release of First-Ever Noninvasive Continuous Hemoglobin Monitor 6Frost & Sullivan Recognizes Excellence in Medical Technologies & Life Sciences 2Frost & Sullivan Recognizes Excellence in Medical Technologies & Life Sciences 3Frost & Sullivan Recognizes Excellence in Medical Technologies & Life Sciences 4Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB) 2Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB) 3Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB) 4Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB) 5Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB) 6
Breaking Biology News(10 mins):Study finds new relationship between gene duplication and alternative splicing in plants 2Study finds new relationship between gene duplication and alternative splicing in plants 3IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2New York autopsies show 2009 H1N1 influenza virus damages entire airway 2New York autopsies show 2009 H1N1 influenza virus damages entire airway 3Prince William Health System Completes Merger With Novant Health to Expand Quality Health Care in Northern Virginia 50528 1Prince William Health System Completes Merger With Novant Health to Expand Quality Health Care in Northern Virginia 50528 2Prince William Health System Completes Merger With Novant Health to Expand Quality Health Care in Northern Virginia 50528 3Finally The Round Diet 21 A Diet Simple Enough that Even a Kindergartener Can Follow It 50523 1Finally The Round Diet 21 A Diet Simple Enough that Even a Kindergartener Can Follow It 50523 2Dr Donnica Moore Advocates that Women Follow a Preventive Dental Health Routine that Includes Crest Pro Health Enamel Shield 50518 1Dr Donnica Moore Advocates that Women Follow a Preventive Dental Health Routine that Includes Crest Pro Health Enamel Shield 50518 2Dr Donnica Moore Advocates that Women Follow a Preventive Dental Health Routine that Includes Crest Pro Health Enamel Shield 50518 3